Skip to Content

Massachusetts governor to push $1 billion investment on stem-cell, other research

BOSTON (AP) – Massachusetts’ governor, eager to attract more biotechnology business, on Tuesday proposed that the state make a $1 billion (euro740 million) investment in the industry to challenge California as a hub of stem-cell research in the United States.

Gov. Deval Patrick’s proposal, revealed in a speech to scientists and biotech companies at the BIO International Convention in Boston, is a 10-year initiative. Money would be spent on research grants to scientists and to improve public college facilities that both public and private researchers would use, he said.

The initiative also calls for the creation of a stem cell bank, a centralized repository of stem cell lines for public and private research. Patrick said the bank would be the first of its kind in the nation.

”There is no place in the world with as much talent in life sciences and biotech as here in Massachusetts. Now is the time for us to invest in that talent and bring together the resources of our unparalleled researched universities, teaching hospitals and industry to work toward a common goal, to grow ideas into products, to create cures and jobs,” Patrick said in a news release.

The proposal would require legislative approval. Both House Speaker Salvatore DiMasi and Senate President Therese Murray voted in favor of a 2005 bill encouraging stem cell research.

The proposal comes at a time when the University of Massachusetts is basking in the glow of a Nobel Prize. Craig Mello, of the UMass Medical School in Worcester, shared the Nobel Prize in medicine last October for discovering a way to silence specific genes, a revolutionary finding that scientists are scrambling to harness for fighting illnesses as diverse as cancer, heart disease and AIDS.

California voters in 2004 approved the nation’s most ambitious stem cell research center. The California Institute for Regenerative Medicine is authorized to dole out $3 billion (euro2.21 billion) in research grants over 10 years.

The research aims to use stem cells, which are created in the first days after conception and can give rise to all the organs and tissues in the body, to replace diseased tissue in hopes of treating a variety of diseases, from Alzheimer’s to diabetes.

But many social conservatives, including President George W. Bush, oppose the work because embryos are destroyed in the process. The microscopic embryos are usually donated by fertility clinics.

The Bush administration has limited federal funding to about $25 million (euro18.44 million) annually.

Four other states also have skirted federal restrictions with stem cell research funding schemes of their own: Connecticut has a 10-year, $100 million (euro73.8 million) initiative; Illinois spent $10 million (euro7.38 million) last year; Maryland has approved a $15 million (euro11.06 million) budget; and New Jersey has spent about $25 million (euro18.44 million) in two years.

Patrick has pushed to reverse stem cell research restrictions imposed by his predecessor, Republican presidential hopeful Mitt Romney.

Keep Reading

Most Popular

A Roomba recorded a woman on the toilet. How did screenshots end up on Facebook?

Robot vacuum companies say your images are safe, but a sprawling global supply chain for data from our devices creates risk.

A startup says it’s begun releasing particles into the atmosphere, in an effort to tweak the climate

Make Sunsets is already attempting to earn revenue for geoengineering, a move likely to provoke widespread criticism.

10 Breakthrough Technologies 2023

Every year, we pick the 10 technologies that matter the most right now. We look for advances that will have a big impact on our lives and break down why they matter.

These exclusive satellite images show that Saudi Arabia’s sci-fi megacity is well underway

Weirdly, any recent work on The Line doesn’t show up on Google Maps. But we got the images anyway.

Stay connected

Illustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.